Heart Test Laboratories I...

AI Score

0

Unlock

3.44
0.04 (1.18%)
At close: Jan 17, 2025, 3:54 PM
3.47
0.87%
After-hours Jan 17, 2025, 03:55 PM EST

Heart Test Laboratories Statistics

Share Statistics

Heart Test Laboratories has 980.32K shares outstanding. The number of shares has increased by -98.5% in one year.

Shares Outstanding 980.32K
Shares Change (YoY) n/a
Shares Change (QoQ) 7.34%
Owned by Institutions (%) n/a
Shares Floating 883.13K
Failed to Deliver (FTD) Shares 281
FTD / Avg. Volume 0.73%

Short Selling Information

The latest short interest is 54.95K, so 5.61% of the outstanding shares have been sold short.

Short Interest 54.95K
Short % of Shares Out 5.61%
Short % of Float 6.27%
Short Ratio (days to cover) 2.41

Valuation Ratios

The PE ratio is -0.49 and the forward PE ratio is -0.46.

PE Ratio -0.49
Forward PE -0.46
PS Ratio 175.12
Forward PS 5.6
PB Ratio 0.45
P/FCF Ratio -0.53
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Heart Test Laboratories Inc. has an Enterprise Value (EV) of 6.62M.

EV / Earnings -1
EV / Sales 356.11
EV / EBITDA -1.08
EV / EBIT -1.05
EV / FCF -1.07

Financial Position

The company has a current ratio of 4.2, with a Debt / Equity ratio of 0.14.

Current Ratio 4.2
Quick Ratio 3.84
Debt / Equity 0.14
Total Debt / Capitalization 12.41
Cash Flow / Debt -5.86
Interest Coverage -17.81

Financial Efficiency

Return on equity (ROE) is -0.9% and return on capital (ROIC) is -75.49%.

Return on Equity (ROE) -0.9%
Return on Assets (ROA) -0.7%
Return on Capital (ROIC) -75.49%
Revenue Per Employee 1.24K
Profits Per Employee -440.35K
Employee Count 15
Asset Turnover 0
Inventory Turnover 0.01

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -71.09% in the last 52 weeks. The beta is 3.29, so Heart Test Laboratories 's price volatility has been higher than the market average.

Beta 3.29
52-Week Price Change -71.09%
50-Day Moving Average 3.36
200-Day Moving Average 4.85
Relative Strength Index (RSI) 48.21
Average Volume (20 Days) 38.35K

Income Statement

In the last 12 months, Heart Test Laboratories had revenue of 18.60K and earned -6.61M in profits. Earnings per share was -18.74.

Revenue 18.60K
Gross Profit 12.52K
Operating Income -6.31M
Net Income -6.61M
EBITDA -6.16M
EBIT -6.31M
Earnings Per Share (EPS) -18.74
Full Income Statement

Balance Sheet

The company has 5.81M in cash and 1.04M in debt, giving a net cash position of 4.77M.

Cash & Cash Equivalents 5.81M
Total Debt 1.04M
Net Cash 4.77M
Retained Earnings -67.36M
Total Assets 7.78M
Working Capital 2.39B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.07M and capital expenditures -125.27K, giving a free cash flow of -6.20M.

Operating Cash Flow -6.07M
Capital Expenditures -125.27K
Free Cash Flow -6.20M
FCF Per Share -17.57
Full Cash Flow Statement

Margins

Gross margin is 67.31%, with operating and profit margins of -33.90K% and -35.51K%.

Gross Margin 67.31%
Operating Margin -33.90K%
Pretax Margin -35.51K%
Profit Margin -35.51K%
EBITDA Margin -33.10K%
EBIT Margin -33.90K%
FCF Margin -33.31K%

Dividends & Yields

HSCS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -544.77%
FCF Yield -183.72%
Dividend Details

Analyst Forecast

The average price target for HSCS is $13.5, which is 292.4% higher than the current price. The consensus rating is "Buy".

Price Target $13.5
Price Target Difference 292.4%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on May 17, 2024. It was a backward split with a ratio of 1:100.

Last Split Date May 17, 2024
Split Type backward
Split Ratio 1:100

Scores

Altman Z-Score -12504.78
Piotroski F-Score 1